76189-0535 Iclusig - CanMED: NDC

Product NDC:

76189-0535

Brand Name:

Iclusig

Generic Name:

Ponatinib Hydrochloride

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: Ponatinib Hydrochloride

Strength: 15.0

Unit: mg/1

Packages:

Code: 76189-0535-30

Description: 30 TABLET, FILM COATED in 1 BOTTLE (76189-535-30)

Effective Date: Dec. 14, 2012

Discontinued: July 26, 2020

Code: 76189-0535-60

Description: 60 TABLET, FILM COATED in 1 BOTTLE (76189-535-60)

Effective Date: Dec. 14, 2012

Discontinued: July 26, 2020

Code: 76189-0535-80

Description: 180 TABLET, FILM COATED in 1 BOTTLE (76189-535-80)

Effective Date: Dec. 14, 2012

Discontinued: July 26, 2020

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox